Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.00 – $0.01
27% from low
Exchange
OTC Link
CS
Borrow rate
0.25%
Easy to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2024 | 2025 | |
|---|---|---|
| Revenue | $0 | $0 |
| Cost of revenue | $0 | $0 |
| Gross profit | $0 | $0 |
| Gross margin | — | — |
| R&D | $0 | $0 |
| Operating income | −$14.8K | −$7.3K |
| EBITDA | −$14.8K | $55.2K |
| Net income | −$14.8K | $55.2K |
| Net margin | — | — |
| EPS (diluted) | -0.00 | 0.00 |
Annual figures · source: Financial Modeling Prep
AOXING PHARM CO INC
No one on the platform currently holds AOXG.
No tracked institution reports a position in AOXG as of their last filing.
No one on the platform has traded AOXG yet.
| +0.00% |
| $291753 |
| — |
| NBIONascent Biotech, Inc. | $0.00 | +0.00% | $86109 | — |
| PZOOPazoo, Inc. | $0.00 | +0.00% | $26882 | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.